Recall: Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging

Description: This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.

Name of product: Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs

Units: About 14,250

Hazard: The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.

Remedy: Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.

Recall date: April 10, 2025

Incidents/Injuries: None reported

Sold At: HEB, Harris-Teeter and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for about $11.

Manufactured in: India

Consumer contact: Kramer Laboratories at 800-824-4894 Monday through Friday 8 a.m. to 5 p.m. ET, e-mail at kramerlabs@emersongroup.com, or online at https://safetussin.com/recall for more information.

Recall number: 25-223